期刊文献+

高效液相色谱法测定去氧氟尿苷在不同介质中的平衡溶解度和表观油水分配系数 被引量:14

Determination of equilibrium solubility of doxifluridine in various media and its apparent oil/water partition coefficient by HPLC
下载PDF
导出
摘要 目的测定去氧氟尿苷在不同介质中的平衡溶解度以及在正辛醇-水和正辛醇-缓冲液体系中的表观油水分配系数。方法采用HPLC法测定去氧氟尿苷的浓度,采用摇瓶法测定去氧氟尿苷的表观油水分配系数。结果37℃,pH=7时去氧氟尿苷在水中的平衡溶解度为2.570 1 g.L-1,在pH<5磷酸盐缓冲液中的平衡溶解度较低;去氧氟尿苷在正辛醇和水相中表观油水分配系数Papp为0.97;当pH<7时,受pH影响不显著,表现为亲水性。结论去氧氟尿苷在水中的平衡溶解度及油水分配系数与介质的pH值有关,可以通过改变pH值,增加该药物新剂型的稳定性。 Objective To determine the equilibrium solubility of doxifluridine in various media and its apparent partition coefficient for the n-octanol-water/buffer solution system.Methods A high performance liquid chromatography was established and used to detect the concentration of doxifluridine.The apparent partition coefficient for the n-octanol-water/buffer solution system of doxifluridine was determined by shaking flask method.Results The equilibrium solubility of doxifluridine in water was 2.570 1 g·L-1 at 37 ℃ and had lower values in acidic phosphate buffer solution.Papp of doxifluridine was 0.97.It was hydrophilic when pH7,and had no significant effect.Conclusion The equilibrium solubility and apparent partition coefficients of doxifluridine are correlated to pH of the medium.The stability of new dosage form of drugs can be increased by changing pH value.
出处 《中南药学》 CAS 2009年第12期923-926,共4页 Central South Pharmacy
关键词 去氧氟尿苷 平衡溶解度 表观油水分配系数 高效液相色谱法 doxifluridine equilibrium solubility apparent oil/ water partition coefficient HPLC
  • 相关文献

参考文献11

二级参考文献16

  • 1National Insititute on Aging. Huperzine A in Alzheimer's disease[DB/OL]. http:∥clinicaltrials.gov/show/NCT00083590,2005-01-03. 被引量:1
  • 2Tang XC, He XC, Bai DL. Huperzine A: a novel acetylcholinesterase inhibitor [J]. Drugs Future, 1999, 24: 647-663. 被引量:1
  • 3Bai DL, Tang XC, He XC. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease [J]. Curr Med Chem, 2000, 7 (3): 355-374. 被引量:1
  • 4Jiang HL, Luo XM, Bai DL. Progress in clinical, pharmacological, chemical and structural biological studies of huperzine A: a drug of traditional Chinese medicine origin for the treatment of Alzheimer's disease [J]. Curr Med Chem,2003, 10 (21):2231-2252. 被引量:1
  • 5Huperzine A.MerckIndex[M].Vol 12,1996.4791. 被引量:1
  • 6赵清治 晁金华 王汉清.注射剂癌得宁中冬凌草甲素含量的紫外分光光度定量测定[J].河南医学院学报,1981,16(2):351-351. 被引量:6
  • 7Miwa M, Sekiguchi F, Akaza H, et al. Comparative studies on the ntitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice [J]. Jpn J Cancer Chemother, 1991, 18(10): 1579 - 1586. 被引量:1
  • 8Baldini E, Tibaldi C, Pfanner E, et al. Phase Ⅱ study of oral doxifluridine in elderly patients with advanced non-small cell lung cancer[J]. Am J Clin Oncol, 1996, 19(6) :592 - 594. 被引量:1
  • 9Bajetta E, Di Bartolomeo M, Somma L, et al. Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-Fu) containing regimens[J ]. Eur J Cancer, 1997, 33 (4): 687 - 690. 被引量:1
  • 10Bajetta E, Biganzoli L, Camaghi C, et al. Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer[J].Cancer, 1998, 83(6): 1136 - 1141. 被引量:1

共引文献95

同被引文献130

引证文献14

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部